Nuvation Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	143.05	62.9	7.87	-	-	-
Revenue Growth	1205.52%	698.96%	-	-	-	-
Cost of Revenue	11.96	9.3	7.08	-	-	-
Gross Profit	12.03	53.6	0.8	-	-	-
Selling, General & Admin	154.48	151.56	69.23	28.53	31.92	24.28
Research & Development	125.55	115.11	524.19	71.29	87.82	69.04
Total Operating Expenses	280.03	266.67	593.42	99.82	119.73	93.32
Operating Income	-150.18	-213.06	-592.63	-99.82	-119.73	-93.32
Interest Income	21.22	21.43	27.06	24.61	7.45	2.96
Interest Expense	-20.34	-13.68	-0.34	-	-	-
Other Non-Operating Income (Expense)	3.22	0.69	-2.03	-0.59	8.09	3.51
Total Non-Operating Income (Expense)	4.1	8.44	24.69	24.02	15.54	6.47
Pretax Income	-145.99	-204.63	-567.94	-75.8	-104.2	-86.85
Net Income	-145.99	-204.63	-567.94	-75.8	-104.2	-86.85
Net Income to Common	-145.99	-204.63	-567.94	-75.8	-104.2	-86.85
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	344	342	269	219	217	198
Shares Outstanding (Diluted)	351	342	269	219	217	198
Shares Change	17.69%	27.07%	22.79%	1.00%	9.52%	102.90%
EPS (Basic)	-0.42	-0.60	-2.11	-0.35	-0.48	-0.44
EPS (Diluted)	-0.43	-0.60	-2.11	-0.35	-0.48	-0.44
EPS Growth	-	-	-	-	-	-
Free Cash Flow	-126.06	-173.78	-130.58	-68.07	-96.48	-68.47
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Per Share	-0.36	-0.51	-0.49	-0.31	-0.45	-0.35
Gross Margin	8.41%	85.22%	10.10%	-	-	-
Operating Margin	-104.99%	-338.72%	-7527.33%	-	-	-
Profit Margin	-102.06%	-325.31%	-7213.76%	-	-	-
FCF Margin	-88.13%	-276.27%	-1658.52%	-	-	-
EBITDA	-148.21	-211.33	-591.94	-99.6	-119.54	-93.13
EBITDA Margin	-103.61%	-335.96%	-7518.66%	-	-	-
EBIT	-150.18	-213.06	-592.63	-99.82	-119.73	-93.32
EBIT Margin	-104.99%	-338.72%	-7527.33%	-	-	-

SEC Filings: 10-K · 10-Q